Long-term outcomes in patients with central and ultracentral non-small cell lung cancer treated with stereotactic body radiotherapy: single-institution experience.

Current problems in cancer(2023)

引用 0|浏览5
暂无评分
摘要
Worse outcomes were obseverd in patients with ultracentral NSCLC than those with central tumors after SABR. Higher rate of treatment-related grade 3 or more toxicity was observed in the ultracentral group.
更多
查看译文
关键词
Non-small cell lung cancer,Stereotactic ablative radiotherapy,Survival,Toxicity,Ultracentral tumor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要